β-Asarone Mediates the Alleviation of Neuroinflammation in Alzheimer's Disease Via Modulation of the TREM2/PI3K/AKT Signaling Pathway. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.